Not all cancer cells are the same, and neither are their responses to drugs. Finding the right drug for the right cancer cell is a long battle in drug development and in designing effective treatments. A new AI tool called ...
Chandler Browning always dreamed of being part of The University of Texas at Arlington's nationally recognized nursing program and pursuing her goal of becoming a certified registered nurse anesthetist. Now in her first semester ...
4 hours ago
0
2
Ivonescimab significantly prolonged overall survival compared with pembrolizumab as first-line treatment for patients with PD-L1-positive advanced non-small cell lung cancer (NSCLC), according to a prespecified interim analysis ...
5 hours ago
0
3
Results from the randomized Phase III ARTEMIS-008 trial show that risvutatug rezetecan (Ris-Rez), a B7-H3-directed antibody-drug conjugate, significantly improved overall survival compared with topotecan in patients with ...
5 hours ago
0
3
A study led by the Barcelona Institute for Global Health (ISGlobal) and Aarhus University shows that children and adolescents diagnosed with attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) ...
13 hours ago
0
68
Sacituzumab govitecan (SG) plus pembrolizumab did not demonstrate a statistically significant improvement in progression-free survival compared with pembrolizumab alone as first-line treatment for patients with metastatic ...
5 hours ago
0
3
The phase 3 TAISHAN-302 trial found that tambotatug pelitecan (Tam-Peli, YL201), a novel anti-B7-H3 antibody-drug conjugate, significantly improved overall survival, progression-free survival and objective response rate compared ...
5 hours ago
0
2
Treating inherited diseases is one of the greatest challenges in modern medicine. In the future, targeted gene corrections at the earliest stages of embryonic development could help prevent certain inherited diseases from ...
10 hours ago
0
5
Results from the international phase 3 SWOG S1827 MAVERICK trial show that brain MRI surveillance alone improved cognitive failure-free survival compared with MRI surveillance plus prophylactic cranial irradiation (PCI) in ...
5 hours ago
0
1
Researchers at Texas A&M University's Naresh K. Vashisht College of Medicine have identified time-specific patterns of brain activity following ketamine treatment in older adults with treatment-resistant depression.
18 hours ago
0
266
